Elizabeth M. Burton, Denái R. Milton, Michael T. Tetzlaff, Khalida Wani, Merrick I. Ross, Michael A. Postow, Rossana Lazcano, Isabella C. Glitza, Michael K. Wong, Sapna P. Patel, Adi Diab, Jeffrey E. Gershenwald, Jennifer L. McQuade, Allison Betof Warner, Victor G. Prieto, Jeffrey E. Lee, Ryan P. Goepfert, Sarah B. Fisher, Addison Song, Jared Malke, Julie M. Simon, Charlotte Ariyan, Carlos A. Torres-Cabala, Michael A. Davies, Alexander Lazar, Jennifer A. Wargo, Hussein A. Tawbi, Rodabe N. Amaria. "Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma." Journal of Clinical Oncology (2025). https://doi.org/10.1200/jco-25-00494